+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inhaled Drug Delivery"

Inhalable Drugs Market Report 2026 - Product Thumbnail Image

Inhalable Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Inhaler Corticosteroid Device Market Report 2026 - Product Thumbnail Image

Inhaler Corticosteroid Device Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Inhaled Drug Delivery market is composed of two main types of devices: inhalers and nebulisers. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that convert liquid medication into a mist that can be inhaled. Both types of devices are used to treat a variety of respiratory conditions, such as asthma, COPD, and cystic fibrosis. Inhalers and nebulisers are used to deliver a range of medications, including bronchodilators, corticosteroids, and antibiotics. Inhalers are typically used for short-term relief of symptoms, while nebulisers are used for long-term management of chronic conditions. Inhaled Drug Delivery is a rapidly growing market, driven by advances in technology and an increasing prevalence of respiratory conditions. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, Novartis, AstraZeneca, and Teva Pharmaceuticals. Show Less Read more